샘플 요청 목록

 카트 문의
시장보고서
상품코드
1997062

MRI 유도하 집속 초음파 치료 시장 규모와 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 대상 범위 : 용도별, 최종사용자별, 지역별

MRI-guided Focused Ultrasound Therapy Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Geography
발행일: | 리서치사: 구분자 The Insight Partners | 페이지 정보: 영문 285 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

MRI 유도하 집속 초음파 치료 시장 규모는 2025년 4억 4,173만 달러에서 2034년까지 10억 2,763만 달러로 확대될 것으로 예상되며, 2026-2034년 10.0%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 대상 질환의 유병률 증가, 기술 발전 및 규제 당국의 승인, 비침습적 치료로의 전환, 고령화 사회는 MRI 유도하 집속 초음파 치료 시장의 확대에 기여하는 주목할 만한 요인입니다. 또한, 휴대용 및 하이브리드 시스템의 개발, 영상 진단 능력과 실시간 온도 측정 기술의 발전은 가까운 미래에 MRI 유도하 집속 초음파 치료 시장에 새로운 트렌드를 가져올 것으로 예측됩니다.

MRgFUS 치료 용도 첨단영상 기술과 순간 온도 측정 기능 개발에 의해 외과적 개입을 필요로 하지 않는 온도 지도제작을 통한, 안전하고 효율적인 조직 파괴를 보증하는 정밀한 모니터링이 가능해집니다.플로톤 공명 주파수 시프트(PRF)에 근거한 MR온도 측정 시스템은 HIFU 온도 변화를 정확하게 추적해, 의사가 시술 전과정을 통해서 조작을 모니터링 하는 것을 가능하게 합니다.경 두개 MRgFUS PRF 온도 측정 시스템은 병변 진행을 정밀하게 모니터링 하기 위해서, 그 임상 사용 기술적 측면을 평가합니다.본시스템은 MR 대체로서 기능하는 실시간 초음파 서모그래피(UST)에 의존하고 있습니다.본시스템은 그래픽스 처리 유닛(GPU) 기술을 활용해, 의료 분야가 MRgFUS 기술을 받아 들인 후 도입을 통해서 1950년대에 거슬러 올라가는 확립된 모니터링 방법을 유지하면서, 고속으로 동작하는 경제적인 모니터링 솔루션을 제공합니다.본시스템은 인텔리전스 기반 서모그래피(IT) 기술을 이용해 FUS 치료를 모니터링 하는 것과 동시에, 연구자등은 열관리를 감독하기 위한 새로운 방법을 평가했습니다.완화적 MRgHIFU 골전이 치료 MR서모메트리는 복수 임상 치료 에비덴스에 의하면, 결과가 낮다고 여겨지는 상반신 영역과 비교하고, 뼈용해 성병 이상하게 추격자보다 양호한 결과를 가져옵니다.7T MRI 시스템은 환자 치료중에 온열 요법이나 약물전달 활동을 모니터링 하는 실시간 온도 측정을 가능하게 해, 전임상 FUS 시스템에서 유효한 결과를 나타내고 있습니다.이러한 기술은 표적 선정과 시스템 감시 양쪽 모두에서 정확한 절차를 가능하게 하기 위한(해), 보다 우수한 보호를 제공합니다.UST 같은 초음파 기반 솔루션 이용은 영상 유도 FUS(IgFUS) 기술에의 액세스를 향상시키는 이치가 되어, 그보다 광범위한 도입을 촉진하겠지요.이 첨단영상 화 방법은 광음향 단층촬영을 기타 기술과 조합하는 것으로, 보다 우수한 조직 가시화 결과를 실현합니다.실시간 온도 측정은 신중하고 정밀한 표적 선정을 통해서 과잉인 에너지 흡수를 회피해야 하는 종양 치료에서 제어된 세포사 패턴 예측과 달성에 도움이 되어, 그것에 의해 MRI 유도하 집속 초음파 치료 시장 중요 동향으로서 부상하고 있습니다.

최종 사용자별 분석

최종 사용자별로 MRI 유도하 집속 초음파 치료 시장은 의료시설, 영상 진단센터, 연구센터로 분류됩니다. 2025년에는 의료시설 부문이 MRI 유도하 집속 초음파 치료 시장에서 가장 큰 점유율을 차지할 것으로 예측됩니다. 의료기관은 본원 및 클리닉이 본태성 진전, 파킨슨병, 자궁근종, 골전이 환자에게 비수술적 치료를 제공할 수 있도록 MRI 유도하집속초음파(MRgFUS) 요법을 필수적인 치료법으로 채택하고 있습니다. 스탠포드헬스케어는 2013년부터 MRgFUS를 이용하여 본태성 진전, 파킨슨병, 전립선암, 골전이, 자궁근종 등을 치료하고 있습니다. 이 치료법을 통해 의사는 인접 부위를 손상시키지 않고 특정 신체 조직을 파괴할 수 있기 때문이라는 것이 이 병원의 임상 프로그램 설명입니다. 메릴랜드대학교 메디컬센터(UMMC)는 본 기술 연구진이 FDA 임상시험을 실시하여 시스템의 승인을 받아 본 기술을 발병성 진전 및 파킨슨병 관련 진전 치료제로 개발했습니다. 현재는 기능성 신경외과 수술에서 교모세포종 치료에 대한 적용에 대한 연구도 진행하고 있습니다. 영국 임페리얼 칼리지 헬스케어 NHS 트러스트(Imperial College Healthcare NHS Trust)는 전문 장비 보조금을 통해 본 기술을 본태성 진전 치료에 적용하고 있으며, 외래 진료에서 저악성 전립선암과 자궁근종 환자 치료에도 활용하고 있습니다.

위상배열 기술을 통해 두개골 천공이 가능해져 개두술 없이 뇌 수술을 할 수 있어 환자의 예후가 개선되고 의료 업무의 효율성이 향상되고 있습니다. FDA는 2004년에 자궁근종 치료, 2012년에 뼈 전이 치료를 승인하여 이러한 시술의 도입이 가속화되었습니다. 한편, 현재 진행 중인 유방암, 간암, 전립선암 임상시험은 광범위한 임상 승인을 목표로 하고 있습니다. 이러한 발전은 다학제 팀에 의한 표적 치료 제공, 입원 기간 단축, 난치성 질환 환자의 삶의 질 향상에 도움을 주며, MRI 유도하 집속초음파 치료 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 MRI 유도하 집속 초음파 치료 시장 구도

제3장 경쟁 구도

제4장 MRI 유도하 집속 초음파 치료 시장 - 주요 시장 역학

제5장 MRI 유도하 집속 초음파 치료 시장 - 세계 시장 분석

제6장 MRI 유도하 집속 초음파 치료 시장 매출 분석 - 용도별

제7장 MRI 유도하 집속 초음파 치료 시장 매출 분석 - 최종사용자

제8장 MRI 유도하 집속 초음파 치료 시장 - 지역 분석

제9장 MRI 유도하 집속 초음파 치료 시장 상황

제10장 MRI 유도하 집속 초음파 치료 시장 - 주요 기업 개요

제11장 추가 분석 대상 기업 리스트

제12장 부록

LSH

The MRI-guided focused ultrasound therapy market size is expected to grow from US$ 441.73 million in 2025 to US$ 1,027.63 million by 2034; it is projected to register a CAGR of 10.0% during 2026-2034. The rising prevalence of targeted diseases, technological advancements and regulatory approvals, and the shift towards noninvasive therapies and an aging population are noteworthy factors contributing to the expansion of the MRI-guided focused ultrasound therapy market size. Additionally, the development of portable and hybrid systems, and enhanced imaging and real-time thermometry are projected to bring new MRI-guided focused ultrasound therapy market trends in the near future.

The development of advanced imaging techniques together with instantaneous temperature measurement capabilities in MRgFUS treatment applications enables precise monitoring which guarantees safe and efficient tissue destruction through temperature mapping that requires no surgical intervention. The proton resonance frequency shift-based MR thermometry system accurately tracks HIFU temperature changes, which enables doctors to monitor their operations throughout the entire procedure. The PRF thermometry system in transcranial MRgFUS evaluates technical aspects of its clinical use to achieve precise monitoring of lesion development. The system relies on real-time ultrasound thermography (UST) which functions as an alternative to MR. The system uses graphics processing unit (GPU) technology to deliver economic monitoring solutions that operate at increased speeds while maintaining established monitoring methods which date back to the 1950s through its implementation after the medical field accepted MRgFUS technology. The system uses intelligence-based thermography (IT) technology to monitor FUS treatment while researchers assess new methods to oversee thermal management. MR thermometry in palliative MRgHIFU bone metastasis treatment provides better results in osteolytic bone-destroying lesions compared to upper body areas which show lower results according to evidence from multiple clinical treatments. The 7T MRI system enables real-time thermometry which monitors hyperthermia and drug delivery activities during treatment of patients, showing effective results in preclinical FUS systems. The techniques provide better protection as they enable exact procedures for both targeting and system supervision. The use of ultrasound-based solutions like UST provides a pathway to enhance the accessibility of image-guided FUS (IgFUS) technology which will promote its wider implementation. The advanced imaging method combines photoacoustic tomography with other techniques to achieve better tissue visualization results. Real-time thermometry helps predict and achieve controlled cell death patterns, in tumor treatments where excessive energy absorption must be avoided through careful and precise targeting, thereby emerging as a significant trend in the MRI-guided focused ultrasound therapy market.

End User-Based Insights

Based on end user, the MRI-guided focused ultrasound therapy market is segmented into healthcare facilities, diagnostic imaging centers, and research centers. The healthcare facilities segment held the largest MRI-guided focused ultrasound therapy market share in 2025. The healthcare facilities have adopted MR-guided focused ultrasound (MRgFUS) therapy as an essential treatment method because it enables hospitals and clinics to provide non-surgical solutions for patients who have essential tremor and Parkinson's disease and uterine fibroids and bone metastases. The Stanford Health Care facility has used MRgFUS since 2013 to treat essential tremor and Parkinson's disease and prostate cancer and bone metastases and uterine fibroids because it enables doctors to destroy specific body tissues while keeping adjacent areas intact according to their clinical program descriptions. The University of Maryland Medical Center (UMMC) developed MRgFUS as a treatment for essential tremor and Parkinson's-related tremors because its researchers conducted FDA clinical trials which led to system approval and now study its use for glioblastoma treatment in functional neurosurgery procedures. The UK-based Imperial College Healthcare NHS Trust applied MRgFUS through specialized equipment grants to treat essential tremor while using the technology to treat patients who have low-grade prostate cancer and uterine fibroids in outpatient settings.

Phased array technology enables skull penetration which allows brain procedures to occur without craniotomy, resulting in better patient outcomes and more efficient medical operations. The FDA approved uterine fibroid treatments in 2004 and bone metastasis treatments in 2012, which led to faster adoption of these procedures, while ongoing breast and liver and prostate cancer trials work toward achieving widespread clinical endorsement. This evolution supports multidisciplinary teams in delivering targeted therapy, minimizing hospital stays, and enhancing quality of life for patients with refractory conditions, thereby fueling the MRI-guided focused ultrasound therapy market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the MRI-guided focused ultrasound therapy market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. MRI-guided Focused Ultrasound Therapy Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 PEST Analysis
  • 2.5 Impact of Artificial Intelligence (AI)
  • 2.6 Product or Technology Roadmap
  • 2.7 Sustainability and ESG Trends
  • 2.8 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. MRI-guided Focused Ultrasound Therapy Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Targeted Diseases
    • 4.1.2 Technological Advancements and Regulatory Approvals
    • 4.1.3 Shift Towards Noninvasive Therapies and Aging Population
  • 4.2 Market Restraints
    • 4.2.1 Regulatory and Approval Challenges
    • 4.2.2 Technical Limitations and Safety Concerns
    • 4.2.3 Lack of Skilled Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Expansion into Oncology Applications
    • 4.3.2 Growth in Emerging Economies
    • 4.3.3 New Product Launches and Innovations
  • 4.4 Future Trends
    • 4.4.1 AI-Driven Treatment Planning and Automation
    • 4.4.2 Development of Portable and Hybrid Systems
    • 4.4.3 Enhanced Imaging and Real-Time Thermometry
  • 4.5 Impact of Drivers and Restraints

5. MRI-guided Focused Ultrasound Therapy Market - Global Market Analysis

  • 5.1 MRI-guided Focused Ultrasound Therapy Market Revenue (US$ Million), 2021-2034
  • 5.2 MRI-guided Focused Ultrasound Therapy Market Forecast and Analysis

6. MRI-guided Focused Ultrasound Therapy Market Revenue Analysis -Application

  • 6.1 MRI-guided Focused Ultrasound Therapy Market Forecasts and Analysis by Application
    • 6.1.1 Breast Cancer
      • 6.1.1.1 Overview
      • 6.1.1.2 Breast Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
      • 6.1.1.3 Breast Cancer
        • 6.1.1.3.1 Benign
    • 6.1.2 Prostate Cancer
      • 6.1.2.1 Overview
      • 6.1.2.2 Prostate Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Liver Cancer
      • 6.1.3.1 Overview
      • 6.1.3.2 Liver Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.4 Pancreatic Cancer
      • 6.1.4.1 Overview
      • 6.1.4.2 Pancreatic Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.5 Breast Lifting and Aesthetic Application
      • 6.1.5.1 Overview
      • 6.1.5.2 Breast Lifting and Aesthetic Application: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.6 Nipple and Areola Preservation
      • 6.1.6.1 Overview
      • 6.1.6.2 Nipple and Areola Preservation: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.7 Post Surgical Applications
      • 6.1.7.1 Overview
      • 6.1.7.2 Post Surgical Applications: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 6.1.8 Other Applications
      • 6.1.8.1 Overview
      • 6.1.8.2 Other Applications: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)

7. MRI-guided Focused Ultrasound Therapy Market Revenue Analysis -End User

  • 7.1 MRI-guided Focused Ultrasound Therapy Market Forecasts and Analysis by End User
    • 7.1.1 Healthcare Facilities
      • 7.1.1.1 Overview
      • 7.1.1.2 Healthcare Facilities: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Diagnostic Imaging Centers
      • 7.1.2.1 Overview
      • 7.1.2.2 Diagnostic Imaging Centers: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Research Centers
      • 7.1.3.1 Overview
      • 7.1.3.2 Research Centers: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)

8. MRI-guided Focused Ultrasound Therapy Market - Geographical Analysis

  • 8.1 North America
    • 8.1.1 North America MRI-guided Focused Ultrasound Therapy Market Overview
    • 8.1.2 North America: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.1.3 North America: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      • 8.1.3.1 Application
        • 8.1.3.1.1 Breast Cancer
        • 8.1.3.1.2 Benign
      • 8.1.3.2 End User
    • 8.1.4 North America: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
      • 8.1.4.1 United States Market
        • 8.1.4.1.1 United States: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.1.4.1.2 United States: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.1.4.1.2.1 Application
            • 8.1.4.1.2.1.1 Breast Cancer
            • 8.1.4.1.2.1.1.1 Benign
          • 8.1.4.1.2.2 End User
      • 8.1.4.2 Canada Market
        • 8.1.4.2.1 Canada: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.1.4.2.2 Canada: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.1.4.2.2.1 Application
            • 8.1.4.2.2.1.1 Breast Cancer
            • 8.1.4.2.2.1.1.1 Benign
          • 8.1.4.2.2.2 End User
      • 8.1.4.3 Mexico Market
        • 8.1.4.3.1 Mexico: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.1.4.3.2 Mexico: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.1.4.3.2.1 Application
            • 8.1.4.3.2.1.1 Breast Cancer
            • 8.1.4.3.2.1.1.1 Benign
          • 8.1.4.3.2.2 End User
  • 8.2 Europe
    • 8.2.1 Europe MRI-guided Focused Ultrasound Therapy Market Overview
    • 8.2.2 Europe: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.2.3 Europe: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      • 8.2.3.1 Application
        • 8.2.3.1.1 Breast Cancer
          • 8.2.3.1.1.1 Benign
      • 8.2.3.2 End User
    • 8.2.4 Europe: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
      • 8.2.4.1 Germany Market
        • 8.2.4.1.1 Germany: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.1.2 Germany: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.2.4.1.2.1 Application
            • 8.2.4.1.2.1.1 Breast Cancer
            • 8.2.4.1.2.1.1.1 Benign
          • 8.2.4.1.2.2 End User
      • 8.2.4.2 United Kingdom Market
        • 8.2.4.2.1 United Kingdom: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.2.2 United Kingdom: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.2.4.2.2.1 Application
            • 8.2.4.2.2.1.1 Breast Cancer
            • 8.2.4.2.2.1.1.1 Benign
          • 8.2.4.2.2.2 End User
      • 8.2.4.3 France Market
        • 8.2.4.3.1 France: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.3.2 France: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.2.4.3.2.1 Application
            • 8.2.4.3.2.1.1 Breast Cancer
            • 8.2.4.3.2.1.1.1 Benign
          • 8.2.4.3.2.2 End User
      • 8.2.4.4 Italy Market
        • 8.2.4.4.1 Italy: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.4.2 Italy: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.2.4.4.2.1 Application
            • 8.2.4.4.2.1.1 Breast Cancer
            • 8.2.4.4.2.1.1.1 Benign
          • 8.2.4.4.2.2 End User
      • 8.2.4.5 Spain Market
        • 8.2.4.5.1 Spain: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.5.2 Spain: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.2.4.5.2.1 Application
            • 8.2.4.5.2.1.1 Breast Cancer
            • 8.2.4.5.2.1.1.1 Benign
          • 8.2.4.5.2.2 End User
      • 8.2.4.6 Rest of Europe Market
        • 8.2.4.6.1 Rest of Europe: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.2.4.6.2 Rest of Europe: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.2.4.6.2.1 Application
            • 8.2.4.6.2.1.1 Breast Cancer
            • 8.2.4.6.2.1.1.1 Benign
          • 8.2.4.6.2.2 End User
  • 8.3 Asia Pacific
    • 8.3.1 Asia Pacific MRI-guided Focused Ultrasound Therapy Market Overview
    • 8.3.2 Asia Pacific: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.3.3 Asia Pacific: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      • 8.3.3.1 Application
        • 8.3.3.1.1 Breast Cancer
          • 8.3.3.1.1.1 Benign
      • 8.3.3.2 End User
    • 8.3.4 Asia Pacific: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
      • 8.3.4.1 China Market
        • 8.3.4.1.1 China: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.1.2 China: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.3.4.1.2.1 Application
            • 8.3.4.1.2.1.1 Breast Cancer
            • 8.3.4.1.2.1.1.1 Benign
          • 8.3.4.1.2.2 End User
      • 8.3.4.2 Japan Market
        • 8.3.4.2.1 Japan: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.2.2 Japan: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.3.4.2.2.1 Application
            • 8.3.4.2.2.1.1 Breast Cancer
            • 8.3.4.2.2.1.1.1 Benign
          • 8.3.4.2.2.2 End User
      • 8.3.4.3 India Market
        • 8.3.4.3.1 India: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.3.2 India: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.3.4.3.2.1 Application
            • 8.3.4.3.2.1.1 Breast Cancer
            • 8.3.4.3.2.1.1.1 Benign
          • 8.3.4.3.2.2 End User
      • 8.3.4.4 Australia Market
        • 8.3.4.4.1 Australia: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.4.2 Australia: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.3.4.4.2.1 Application
            • 8.3.4.4.2.1.1 Breast Cancer
            • 8.3.4.4.2.1.1.1 Benign
          • 8.3.4.4.2.2 End User
      • 8.3.4.5 South Korea Market
        • 8.3.4.5.1 South Korea: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.5.2 South Korea: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.3.4.5.2.1 Application
            • 8.3.4.5.2.1.1 Breast Cancer
            • 8.3.4.5.2.1.1.1 Benign
          • 8.3.4.5.2.2 End User
      • 8.3.4.6 Rest of APAC Market
        • 8.3.4.6.1 Rest of APAC: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.3.4.6.2 Rest of APAC: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.3.4.6.2.1 Application
            • 8.3.4.6.2.1.1 Breast Cancer
            • 8.3.4.6.2.1.1.1 Benign
          • 8.3.4.6.2.2 End User
  • 8.4 Middle East and Africa
    • 8.4.1 Middle East and Africa MRI-guided Focused Ultrasound Therapy Market Overview
    • 8.4.2 Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.4.3 Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      • 8.4.3.1 Application
        • 8.4.3.1.1 Breast Cancer
          • 8.4.3.1.1.1 Benign
      • 8.4.3.2 End User
    • 8.4.4 Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
      • 8.4.4.1 Saudi Arabia Market
        • 8.4.4.1.1 Saudi Arabia: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.1.2 Saudi Arabia: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.4.4.1.2.1 Application
            • 8.4.4.1.2.1.1 Breast Cancer
            • 8.4.4.1.2.1.1.1 Benign
          • 8.4.4.1.2.2 End User
      • 8.4.4.2 South Africa Market
        • 8.4.4.2.1 South Africa: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.2.2 South Africa: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.4.4.2.2.1 Application
            • 8.4.4.2.2.1.1 Breast Cancer
            • 8.4.4.2.2.1.1.1 Benign
          • 8.4.4.2.2.2 End User
      • 8.4.4.3 United Arab Emirates Market
        • 8.4.4.3.1 United Arab Emirates: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.3.2 United Arab Emirates: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.4.4.3.2.1 Application
            • 8.4.4.3.2.1.1 Breast Cancer
            • 8.4.4.3.2.1.1.1 Benign
          • 8.4.4.3.2.2 End User
      • 8.4.4.4 Rest of Middle East and Africa Market
        • 8.4.4.4.1 Rest of Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.4.4.4.2 Rest of Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.4.4.4.2.1 Application
            • 8.4.4.4.2.1.1 Breast Cancer
            • 8.4.4.4.2.1.1.1 Benign
          • 8.4.4.4.2.2 End User
  • 8.5 South and Central America
    • 8.5.1 South and Central America MRI-guided Focused Ultrasound Therapy Market Overview
    • 8.5.2 South and Central America: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 8.5.3 South and Central America: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      • 8.5.3.1 Application
        • 8.5.3.1.1 Breast Cancer
          • 8.5.3.1.1.1 Benign
      • 8.5.3.2 End User
    • 8.5.4 South and Central America: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
      • 8.5.4.1 Brazil Market
        • 8.5.4.1.1 Brazil: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.5.4.1.2 Brazil: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.5.4.1.2.1 Application
            • 8.5.4.1.2.1.1 Breast Cancer
            • 8.5.4.1.2.1.1.1 Benign
          • 8.5.4.1.2.2 End User
      • 8.5.4.2 Argentina Market
        • 8.5.4.2.1 Argentina: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.5.4.2.2 Argentina: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.5.4.2.2.1 Application
            • 8.5.4.2.2.1.1 Breast Cancer
            • 8.5.4.2.2.1.1.1 Benign
          • 8.5.4.2.2.2 End User
      • 8.5.4.3 Rest of South and Central America Market
        • 8.5.4.3.1 Rest of South and Central America: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 8.5.4.3.2 Rest of South and Central America: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
          • 8.5.4.3.2.1 Application
            • 8.5.4.3.2.1.1 Breast Cancer
            • 8.5.4.3.2.1.1.1 Benign
          • 8.5.4.3.2.2 End User

9. MRI-guided Focused Ultrasound Therapy Market Industry Landscape

10. MRI-guided Focused Ultrasound Therapy Market - Key Company Profiles

  • 10.1 Edap Tms SA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Insightec Ltd.
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Koninklijke Philips NV
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 FUS Instruments Inc.
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Image Guided Therapy SA
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Profound Medical Corp.
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Arrayus Technologies Inc.
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 EpiSonica
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 NaviFUS Corp.
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Changjiangyuan Technology Development Co. Ltd.
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. List of Additional Companies Analyzed

  • 11.1 List of Additional Companies Analyzed

12. Appendix

  • 12.1 Glossary
  • 12.2 Research Methodology and Approach
    • 12.2.1 Secondary Research
    • 12.2.2 Primary Research
    • 12.2.3 Market Estimation Approach
      • 12.2.3.1 Supply Side Analysis
      • 12.2.3.2 Demand Side Analysis
    • 12.2.4 Research Assumptions and Limitations
    • 12.2.5 Currency Conversion
  • 12.3 About The Insight Partners
  • 12.4 Market Intelligence Cloud
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제